Rami Suzuki, PhD

President, Senior Group Officer, Global Business Development Unit, ECL Eisai Co., Ltd.

RamiSuzuki20150218Rami Suzuki Ph.D. is Senior Group Officer, President, Global Business Development Unit ECL of Eisai Co, Ltd, a multinational pharmaceutical company headquartered in Tokyo. She is responsible for corporate business development, M&A, public-private partnerships and alliance for Japan, Asia and China. After managing a life science venture capital fund for Europe at ITX Corporation, she joined Eisai in 2004. Rami’s lifetime missions are to cure cancer and to prevent dementia.